FocalTherics™ Announces Successful Launch of First Commercial Endometriosis Focal One® Program in Europe with Treatment of Initial Patients
Go back to FocalTherics™ Announces Successful Launch of First Commercial Endometriosis Focal One® Program in Europe with Treatment of Initial Patients| (NASDAQ: FOCL) | Delayed: 6.09 +0.21 (3.57%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $5.88 | 52 Week High | $ | |||
| Open | $5.96 | 52 Week Low | $ | |||
| Day High | $6.18 | P/E | N/A | |||
| Day Low | $5.76 | EPS | $ | |||
| Volume | 92,554 | |||||

